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Protéomique du liquide amniotique 
Résumé: 
Le liquide amniotique est essentiel pour le développement du fœtus durant la grossesse. Sa 
production est directement associée à l'intégrité fonctiom1elle des compartiments fœtal, 
placentaire et amniotique. Le liquide amniotique étant produit et modifié durant la grossesse 
par différents sites, son profil protéique reflète les changements physiologiques et 
pathologiques du fœtus et de la mère. 
Différentes techniques d'électrophorèse bidimensiom1elle, couplées à l'analyse par 
spectrométrie de masse, on été utilisées pour : 
i) déterminer le potentiel analytique de ces méthodes dans l'identification de biomarqueurs. 
Différentes quantités d'inhibiteur de la trypsine de soja et de myoglobine équine ont été 
ajoutées au liquide amniotique. Dans ce modèle, une quantité minimale de 5 à 10 ng de ces 
biomarqueurs artificiels ont été détectés. 
ii) évaluer la place de ces méthodes dans la comparaison de liquides amniotiques issus de 
grossesses normales, obtenus à 17 semaines d'aménorrhée et à terme, et de grossesses où le 
fœtus présentait une hernie diapln·agmatique congénitale. Les protéines exprimées de manière 
différentielles ont été identifiées. 
Finalement, le potentiel de l'électrophorèse bidimensionnelle a été évalué par l'étude de 
plasma contenant des protéines spécifiques du liquide amniotique dans un modèle de rupture 
prématurée des membranes. Les résultats obtenus montrent que les teclmologies utilisant 
l'électrophorèse bidimensimmelle gardent leur place dans l'analyse de liquides biologiques, 
tel le liquide amniotique. 
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Two-Dimensional Gel Electrophoresis Based Technologies for Potential 
Biomarkers Identification in Amniotic }.,luid: A Simple Model 
P.-A. Queloz1, D. Crettaz1, L. Thadikkaran1, V. Sapin2 and J.-D. Tissot1'* 
1Service régional vaudois de Transfusion Sanguine, Lausanne, Switzerland,' 2CHU, Laboratoire de Biochimie Médicale, 
F-63000, Clermont-Ferrand, France 
Abstract: To assess the efficiency of two-dimensional fluorescence difference gel electrophoresis (2D-D IGE) and of two-
dimensional electrophoresis and ammoniacal silver staining (2D-E), different amounts of soybean trypsin inhibitor and 
horse myoglobin were added to amniotic fluid. In this mode!, a minimum of 5 to 10 ng of "artificial" biomarkers was de-
tected. 
Keywords: Amniotic fluid, Biomarker, CyDye, Proteomics, Two-dimensional electrophoresis. 
INTRODUCTION 
Amniotic fluid (AF) is essential for fetus devel0pment 
during pregnancy. lts production is directly related to the 
functional integrity of the fetal, placenta! and amniotic com-
partments and varies throughout pregnancy (reviewed in 
[ 1 ]). Sin ce AF is produced and modified throughout preg-
nancy by different sites, the protein profile of AF would re-
flect bath physiological and pathological changes, which 
affect the fetus and the mother. Preliminary proteomic works 
yet published on AF have been Iimited to identify specific 
proteins of the amniotic fluid as potential biomarkers with 
promising resuits [2-8]. Here, we used 2D fluorescence dif-
ference gel electrophoresis (2D-DIGE; Ettan™ DIGE) as 
well as 2D-E and silver staining to assess the analytîcal po-
tential ofthese methods to identify biomarkers in AF. 
MATERIAL AND METHODS 
Samples Preparation 
Pure normal AF samples were obtained from women at 
term after informed consent as previously described [3]. AF 
proteins were concentrated to 34 mg/ml using Vivaspin Con-
centrator (eut-off 5 kDa) from Vivascience (Hannover, Ger-
many). AF protein concentrations were measured by a pro-
tein-dye binding coloring method [9], using albumin as stan-
dard. Lyophilized soybean trypsin inhibitor (Kunitz-type 
trypsin inhibitor A) was purchased from Fluka Chemie 
(Buchs, Switzerland) whereas lyophilized horse myoglobin 
was obtained from Sigma-Aldrich Chemie (Steinheim, Ger-
many). These two components were used as artificial bio-
markers. The lyophilized biomarker proteins were diluted in 
"buffer A" (urea 8 M, TRIS 40 mM and CHAPS 4%). Vari-
ous volumes of the latter solution were added to AF in order 
to obtained AF containing artificial biomarkers (BAF). BAF 
samples containing from 1 ng to 500 ng of each biomark 
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ers/50 µg of AF proteins were prepared. Control AF samples 
(CAF) were prepared similarly, but without biomarkers. 
2D-E, Silver Staining, Gel Analysis and MALDI-TOF 
MS 
For.2D-E and ammoniacal silver staining, 25 µg of pro-
teins were loaded onto the first dimension isoelectric gels. 
Ali methods have been described in detail elsewhere [3,10-
13]. Briefly, isoelectric focusing was performed under paraf-
fin oil, using Iinear immobilized pH gradients (Immobiline 
Dry-Strip, pH range 3-10, 18 cm) from GE Healthcare 
(Uppsala, Sweden). The strips were rehydrated in a solution 
containing 8 M urea, 2% CHAPS, 10 mM DTE, 2% Pharma-
lyteTM pH 3-10, and traces of bromophenol blue. Samples 
were then loaded on the cathodic side of the gels. After the 
migration, strips were placed on the top of 9-16% gradient 
polyacrylamide gels for the second dimension. 
Ammoniacal silver staining was done according to stan-
dard protocols [10]. Briefly, at the end of the run, the gels 
were washed in water, then soaked in ethanol:acetic 
acid:water (40:10:50) for 1 h and ethanol:acetic acid:water 
(10:5:85) overnight. After a water wash, the gels were 
soaked 30 min in glutaraldehyde (1 %) buffered with sodium 
acetate (0.5 M) and then washed with water. The gels were 
soaked in a 2,7-naphtalenedisulfonic acid fresh solution 
(0.05%, w/v) for 30 min and rinsed again with water. The 
gels were stained in a freshly made ammoniacal silver nitrate 
solution for 30 min . The images were finally developed in a 
solution containing citric acid (0.01 %, w/v) and formalde-
hyde (0.1 %, w/v). Development was stopped with an acetic 
acid:water (5:95) solution. The silver stained gel images 
were captured with high resolution (Pixel size 100 micron) 
densitometry reading with the Persona! Laser Densitometer 
(GE Healthcare). Ail informatic analyses were performed 
with the software ImageMaster 2D Platinum (GE 
Healthcare). 
For preparative gels, 125 µg of proteins were loaded onto 
the gels and Coomassie Blue staining was performed. 
Briefly, after the run, the gels were washed several times 
with water and incubated overnight with Colloidal Coomas-
© 2006 Bentham Science Publishcr·s Ltd. 
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sie Blue Brilliant. Gels were then rinsed and stained spots 
were identified by MALDI-TOF, as described elsewhere 
[3,11,12]. 
Sam pie Labeling for 2D-DIGE and Scanning 
Each protein sample was labeled with CyDye DIGE 
Fluor · according to the manufacturer instructions (GE 
Healthcare) . BAF and CAF samples (50 µg of pro-teins) were 
diluted in "buffer A" to a final volume of 30 µ!. Cyanine 
dyes were reconstituted in 99.8% anhydrous N,N-
dimethylformamide from Sigma (Steinheim, Germany), and 
added to labeling reactions in a ratio of 400 pmol CyDye to 
50 µg protein. Protein labeling was achieved by incubation 
on ice in the dark for 30 min. The reaction was quenched by 
the addition of 2 µl of 10 mM lysine from Sigma (Steinheim, 
Germany), followed by incubation on ice for a further 10 
min. The samples were separately labeled, BAF with Cy5 
and CAF with Cy3. They were then mixed and diluted to a 
final volume of 1 OO µl by adding "buffer B" (urea 7 M, 
thiourea 2 M, CHAPS 4%, OTE 2%, pharmalyte 3-10 2% 
and pharmalyte 4-7 1 %) , and loaded onto the first dimension 
gels (cup loading). CyDye labeled gels were finally scanned 
using a Typhoon 9400 Variable Mode Imager (Pixel size 1 OO 
micron; GE Healthcare). 
RESUL TS AND DISCUSSION 
As shown by (Fig. 1), soybean trypsin inhibitor (Swis-
sprot PO 1070; M, 24275, calculated pl 4.99) were resolved as 
Que/oz et al. 
a double overlapping spot in an area of the gel corresponding 
to 23 - 26 kDa and pl of 4.5 to 5, whereas horse myoglobin 
(Swissprot P68082; M, 16941, calculated pl 7.36) was de-
tected as two separate spots in an area corresponding to 16 -
17 .kDa and pl of 7 to 8. No other contaminant spots ap-
peared in the gel, meaning that the purity of the two artificial 
biomarkers was adequate for the study. Fig. (2) shows the 
detection of the two artificial biomarkers in AF (50 ng of 
each biomarker). The detection limit was identical for 20-
DIGE and 20-E with ammoniacal silver staining, and was of 
10 ng for trypsin inhibitor and of 5 ng for horse myoglobin 
(Fig. 3). In our hands, a final amount of 1 OO ng of each bio-
marker was necessary to be detected after staining with col-
loidai° Coomassie Blue Brilliant. When analyzed by MALDI-
TOF MS, colloïdal Coomassie Blue Brilliant stained spots 
were correctly identified. The sequence coverage was identi-
cal (31 % for trypsin inibitor and 80% for horse myoglobin) 
when either 1 OO or 500 ng of Coomassie stained proteins 
were analyzed. ln optimized conditions , the 20-DIGE sys-
tem was claimed to be able to detect protein amounts down 
to 15 pg per spot, whereas silver staining technolôgies ap-
peared to be limited to detect about 1 ng per spot [14,15]. 
We have to mention here, that the objective of our study was 
to find the detection limit of artificial biomarkers in an envi-
ronment rich in proteins (50 µg). In our study, 5 to 10 ng of 
each biomarkers were clearly identified , when 1 OO )l.g (50 µg 
BAF and 50 µg CAF) were loaded on the gels. The settings 
of the PMT scanner (600 to 650 volt) were chosen in order to 
try to detect both high and low abundance proteins. Higher 
Figure 1: 2D image of a mixture of soybean trypsin inhibitor ( 40 ng; spot# 1) and of horse myoglobin ( 40 ng, spots #2 and #3), stained with 
Cy5. 
Pote/Ilia/ Biomarkers Jde11tijicatio11 i11 A11111iotic Fluid 
CyDye 
Silver staining 
Colloïdal Coomassie 
blue brilliant 
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Figure 2: Comparison of the 2D patterns of amniotic fluid proteins without addition of artificial biomarkers (stained with Cy3, in set in green) 
with that of amniotic fluid proteins with addition of 50 ng of trypsin inhibitor and 50 ng of horse myoglobin (stained with Cy5, inset in red). 
Fifty µ.g of proteins of each stained samples were mixed and loaded on immobilized 3 to 10 non linear pH gradient followed by second di-
mension (9 to 16% polyacrylamide gel electrophoresis. The large 2D gel represents the composite image, and most of the spo.ts, common to 
the two samples, were detected in yellow. The areas of the gels con-esponding either to trypsin inhibitor or to horse myoglobin are highlighted 
by the frames . The spots con-esponding either to trypsin inhibitor or to horse myoglobin are clearly evidenced as additional spots stained in 
red, in the composite image. These spots were also detected after silver staining (50 ng) and also after colloidal Coorriassie Blue Brilliant 
staining but with higher amount ofbiomarkers (500 ng). 
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Figure 3: H istograms (%volume) of the spots of soybean trypsin inhibitor (spot # 1) and of horse myoglobin (spots #2 and #3 ), measured 
according to the different stain ing procedures, at different concentrations. Note that spot #3 of horse myoglobin was not detected using 
Coomassie Blue. 
voltage values allowed a lower detection threshold, but was 
associated with a saturation of the high concentrated proteins 
present in AF. For 20-E and silver staining, 5 ng of proteins 
were identified when a maximum of 25 µg of AF proteins 
were loaded, because at higher protein content, the silver 
stained images were of poor quality (data not shown). The 
ratio bet\veen the amount of biomarker to the total amount of 
proteins loaded were 1120'000 using 20-DIGE, and l/5'000 
with 20-E and ammoniacal silver staining. However, the 
number of spots detected after silver staining of 25 µg of AF 
proteins (N=4; 778 ± 65; mean ± SO) was higher (P=0 .015, 
t-test) than those observed after labeling of 50 µg of AF pro-
teins with CyOye (648 ± 67; N=4; mean ± SO). Clearly, 
combining the t\vo techniques may be a valuable approach 
for biomarker screening in biological fluids. Interestingly, 
recent studies have clearly shown that ammoniacal silver 
staining does not preclude MS analysis [16]. Therefore, im-
age analysis can be combined with protein identification in a 
single experiment. Furthermore, the Eriochrome black T-
silver method, which incorporates a new silver sensitizer, 
was shown to considerably increase the limit of detection of 
proteins after staining (up to 0.05 ng) with the advantage to 
be MS compatible at quantities of 3 to 6 ng of proteins [ 17]. 
Our results show that models such as the one described in 
this study should be used when different techniques are 
compared. By knowing the limits of detection of 20 based 
technologies, the best approach can be chosen, taking into 
account the costs of both equipments and reagents that will 
be used. 
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Abstract 
Amniotic ftuid (AF) is a potential source of biomarkers for many disorders which may occur during pregnancy. The purpose of this study 
was to evaluate the place of two-dimensional gel electrophoresis (2-DE) technologies to compare AF in both normal and pathological situations. 
Two-dimensional fluorescence difference gel electrophoresis (2D-DIGE; Ettan TM DIGE) as well as two-dimensional gel electrophoresis and sil ver 
staining followed by image analysis were used. Differentially expressed proteins were identified by mass spectrometry. This approach was used 
to study electrophoregrams of normal AF obtained at 17 weeks of gestation and at term, as well as AF from fetuses presenting with congenital 
diaphragmatic hernia. Finally, the potential of two-dimensional electrophoresis was assessed by studying the protein profile of plasma containing 
AF pro teins in a mode! of premature rupture of the membranes (PROM). Our results clearly show that two-dimensional electrophoresis technologies 
still have place for analyzing biological fluids such as AF. 
© 2006 Elsevier B.V. Ali rights reserved. 
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1. Introduction 
The biological composition of amniotic fluid (AF) is modified 
throughout pregnancy. Its protein profile reflects both physiolog-
ical and pathological changes affecting the fetus and the mother. 
A number of proteomic studies have been published on AF, 
and have been recently reviewed [1,2] . Michel et al. identified a 
series of AF proteins that were absent from plasma, and therefore 
may be potential markers of premature rupture of membranes 
(PROM) [3] . In addition, several groups were able to identify 
proteins that apperu· useful for the diagnosis of intra-arnniotic 
inflammation [ 4-8] . 
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Since more than 25 years, two-dimensional gel electrophore-
sis (2-DE) has been used to identify nove! biological mru·kers 
that can eventually be used for early detection and/or disease 
diagnosis . Here, we evaluated the role of 2-DE and sil ver stain-
ing as well as of 2D fluorescence difference gel electrophoresis 
(2-D-DIGE; Ettan TM DIGE) to compru·e normal proteomic pro-
files of AF obtained either at 17 or 40 weeks of pregnancy with 
th ose of fetuses presenting with congenital diaphragmatic hernia 
(CDH). 
2. Material and methods 
2.1 . Samples preparation 
Pure normal AF samples (30 ml - about 3 mg/ml protein) were 
obtained after informed consent as previously desc1ibed [9]. AF 
were obtained either at 17 (N = 7) or 40 weeks of pregnancy 
(N=7). 
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AF and fetal tracheal ftuid (TF) were collected from three 
fetuses requiring a fetoscopic tracheal occlusion procedure 
(FETO) for severe left-sided CDH (intra-thoracic liver migra-
tion and lung-to-head ratio <1). Ali procedures were performed 
under the supervision ôf one of us (JD) after extensive coun-
seling and written informed consent of the mother as described 
elsewhere [ 10, 11]. Briefty, 5 ml of amniotic and tracheal ftuid 
were taken during the placement (28 weeks of gestation) and 
removal (34 weeks of gestation) of the tracheal balloon. Sam-
ples were immediately centrifuged and frozen. After thawing, 
protein concentrations were measured by a protein-dye binding 
coloring method [12], using albumin as standard. The following 
samples , from three different fetuses, were studied: TF before 
(TFB) and after plug (TFA), and AF before (AFB) and after plug 
(AFA). 
2.2. 2-DE, silver staining, gel analysis and MS 
The methods have been described in detail elsewhere [13]. 
Briefty, isoelectric focusing (IEF) was performed under paraf-
fin oil, using linear non-immobilized pH gradients (Immobiline 
Dry-Strip, pH range 4-7, 18 cm from (GE Healthcare, Otelfin-
gen, Switzerland). Samples were loaded on the cathodic side 
of the gels. Before the second dimension, strips were equili-
brated and placed on the top of9-16% gradient polyacrylamide 
second dimensional gels. At the end of the run, the gels were 
stained in a freshly made ammoniacal silver nitrate solution. 
The silver-stained gel images were captured with high resolution 
densitometry reading with the Persona! Laser Densitometer from 
GE Healthcare. Ail informatic analyses were performed using 
the software ImageMaster 2D Platinium (GE Healthcare). Spots 
were detected automatically. Manual spot editing (separation of 
two spots) or deleting (artifacts) was then performed manually. 
Spots of interest were identified by MALDI-TOF-TOF MS, as 
described elsewhere [14]. The MASCOT scores, was expressed 
as -10 x log1o(P), where P was the absolute probability that 
the oqserved match was a random event. So, from the scores, 
it was possible to calculate the theoretical probability that the 
found match was a randorn one, and these were listed in Table 1 
as P. Theoretically, it was also possible to calculate the inverse 
probability (1-P) which was the probability of a match being 
non random. Each protein score in a peptide mass fingerprint, 
and each ions score in an MS/MS search, was accompanied by 
an expectation value. This is the number of matches with equal 
or better scores that were expected to occur by chance alone. 
It was directly equivalent to the E-value in a Blast search result 
and was also given in Table 1. Finally, ail our matches have been 
manually examined and validated on the basis of the mass errors 
and the series of.matched ions. 
2.3. Sample labeling for 2D-DIGE and scanning 
Prior to Cy Dye labeling, pro teins were concentrated using 
Vivaspin Concentrator (eut-off 5 kDa) from Vivascience (Han-
nover, Germany). The labeling was performed according to the 
manufacturer instructions (GE Healthcare). Fifty µg of pro-
teins were diluted in a buffer containing urea 8 M, TRIS 40 mM 
.and CHAPS 4% to a final volume of 30 µ!. Cyanine dyes were 
reconstituted in 99 .8% anhydrous N,N-dimethylformamide from 
Sigma (Steinheim, Germany), and added to labeling reactions 
in a ratio of 400 pmol CyDye to 50 µg protein. Protein label-
ing was achieved by incubation on ice in the dark for 30 min. 
The reaction was quenched by addition of 2 µlof 10 mM lysine 
from Sigma, followed by incubation on ice for a further 10 min. 
The different samples to be compared were separately "stained" 
either with Cy5 or Cy3 . They were then mixed and diluted to a 
final volume of 100 µl by adding a buffer containing urea 7 M, 
thiourea 2M, CHAPS 4%, DTE 2%, pharmalyte 3-10 (2%) and 
pharmalyte 4-7 ( 1 % ), and loaded onto the first dimension gels 
(cup loading). CyDye fluor labeled gels were finally scanned 
using a Typhoon 9400 Variable Mode Imager (GE Healthcare). 
3. Results 
3.1. Dijferential protein pattern of AF at term versus AF at 
!7th week of pregnancy 
Fig. 1 shows differential CyDye staining of AF proteins, with 
proteins paiticularly more abundant at term being stained in 
green, whereas proteins more abundant at l 7th week of gesta-
tion being stained in red in the composite image. Among the 
differentially expressed protein spots, seven were identified by 
tandem MS, and corresponded to five different gene products. 
Sorne of their characteristics are summai·ized in Table 1. The 
SPARC precursor (Swissprot P09486), collagen alpha 1 (I) chain 
(P02452) and collagen alpha L(III) chain (P02461) were more 
abundant at 17 weeks of pregnancy, whereas protein Plunc and 
lipocalin~ 1 were more expressed at term. In order to confirm 
our results, an independent 2-DE analysis with silver stained 
gels was performed. Globally, 1000 ± 141 spots (mean ± SD; 
N = 7) for the term samples and 890 ± 187 spots (mean ± SD; 
N = 7) for the 17-week samples were detected on the gels. The 
difference in the number of spots was not statistically significant 
(t-test, P = 0.238). However, ascendant heuristic clustering anal-
ysis efficiently discriminated the protein pattern of AF at term 
from that of AF at 17 weeks . When the seven spots showing a 
clear differential expression between 40 and 17 weeks of preg-
nancy at 2D-DIGE analysis were expressed as their %volume in 
our independent 2-DE sil ver staining analysis, the same differ-
ences were observed (N = 7 in each groups, t-test, ail ?-values 
<0.005). 
3.2. Acidic shift of trachealjluid proteins before plug in 
fetuses presenting with CDH 
Two sets of AF (placement and removal of the balloon) from 
three fetuses presenting with CDH were compai·ed with control 
AF obtained at 17 weeks of pregnancy and at te1m. The protein 
pattern of AF with CDH (1017 spots± 145) segregated frorn 
the one of control AF at 17 weeks, when analyzed by ascendant 
heuristic clustering of silver stained gels. When a seai·ch was 
performed in order to detect the spots discriminating the two 
groups, the same set of spots discriminating AF at 17 weeks and 
at term were identified. Clustering was due to the "age" of the 
w 
w 
Table 1 OO 
Spots identified by MS/MS using MASCOT 
Spot# SwissProt ID Abbreviation Start End MASCOT-peptides identified M, p/ Mascot score Coverage (%) p E-value Comments 
P09486 SPRCJfüMAN 34'629 4.73 195 35 3.16E-20 l.I OE-14 Regulate cell growth, expressed at high 
levels in ti ssues undergoing 
morphogenesis and remodelling 
141 150 K.LHLDYIGPCK.Y (Ions score 49) 
151 166 K.YlPPCLDSELTEFPLR.M (Ions score 46) 
173 181 K.NVLVTLYER.D (Ions score 10) 
206 218 R.LEAGDHPVELLAR.D (Ions score 21) 
2 P09486 SPRCHUMAN 34'629 4.73 117 31 2E-12 l .40E-07 
141 150 K.LHLDYIGPCK.Y (Ions score 37) 
15 1 166 K.YlPPCLDSELTEFPLR.M (Ions score 5) 
206 218 R.LEAGDHPVELLAR.D (Ions score 22) 
3 P09486 SPRC..HUMAN 141 150 K.LHLDYIGPCK.Y (Ions score 42) 34'629 4.73 188 33 1.58E-19 2.30E-15 
151 166 K.YlPPCLDSELTEFPLR.M (Ions score 21) '."t> 
173 181 K.NVLVTLYER.D (Ions score 18) ;;. 
205 218 K.RLEAGDHPVELLAR.D (Ions score 19) lS? ~ 
206 218 R.LEAGDHPVELLAR.D (Ions score 23) è 
N 
4 P02452 COIAl..HUMAN 138'883 5.66 228 Il l.58E-23 l.IOE-18 Member of fibrillar forming collagen, ~ 
forms the fibrils of tendon , ligaments "' ,_ 
and bones ' ,.... 
1226 1236 R.DRDLEVDTTLK.S (Ions score 47) g 
1237 1246 K.SLSQQŒNIR.S (Ions score 69) Cl 
1264 1270 K.MCHSDWK .S Oxidation (M) (Ions score ;::; 
"' 20) ,g 
1372 1386 K.NSVAYMDQQTGNLKK.A Oxidation 
'"' (M) (Ions score 27) t>:i 
1387 1399 K.ALLLKGSNEIEIR.A (Ions score 38) ~ a 
P02461 C03Al..HUMAN 13'8555 6.18 245 Il 3.16E-25 2.30E-20 Occurs along with type 1 collagen "N a 
1240 1255 K.SVNGQIESLISPDGSR.K (Ions score 61) a 
-:::! 
1267 1273 K.FCHPELK .S (Ions score 18) 
""' 1274 1286 K.SGEYWVDPNQGCK.L (Ions score 73) ""' t 1408 1419 K.FTYTVLEDGCTK.H (Ions score 54) 
... 
"' 6 Q9NP55 PLUNCHUMAN 26'712 5.42 259 34 1.26E-26 8.60E-23 Involved in the airway inflammatory 
response, may play arole in inate 
immune responses of the upper airways 
95 109 K.VTSVIPGLNNIIDIK.V (Ions score 61) 
95 109 K.VTSVLPGLNNILDIK.V (Ions score 36) 
110 128 K.VTDPQLLELGLVQSPDGHR.L (Ions 
score 68) 
129 138 R.LYVTlPLG IK. (Ions score 39) 
139 152 K.LQVNTPLVGASLLR.L (Ions score 25) 
157 167 K.LDITAEILAVR.D (Ions score 41) 
214 232 K.VLPELYQGNVCPLVNEVLR.G (Ions 
score 25) 
7 P31025 LCNl..HUMAN 19'250 5.39 32 6 0.00063 1 0.055 Binding of various li gands, main ly 
expressed in lachrymal and salivary 
glands 
140 150 K.NNLEALEDFEK.A (Ions score 32) 
The nurnbering corresponds to that of Fig. 1. 
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Fig. 1. Two-dimensional electrophoretic technologies evaluating AF samples obtained at term (labeled 40) or at 17 weeks of pregnancy (labeled 17). Color images 
show comparison of the 2D patterns of AF at term, 50 µ,g of proteins "stained" using 400 pmol of Cy5 (false color in red, inset labeled A) and of AF at l 7 weeks, 
50 µ,g of proteins were "stained" using 400 pmol of Cy3 (false color in green, inset labeled B). Both samples were mixed and loaded on immobilized four to seven 
non linear pH gradient followed by second dimension (9 to 16% polyacrylamide gel electrophoresis). 2D-DIGE clearly showed seven spots which were differently 
expressed between AF samples at term or at l 7 weeks of pregnancy (panel C). The differential expression of these proteins spots were confirmed by individual 
spot analysis on different collected samples (%volume; /-test, ail ?-values <0.005 , histograms on the right of the Figure) after 2-DE and silver staining of samples 
obtained at term (N = 7) and samples obtained at 17 weeks of pregnancy (N = 7). Details of sil ver stained gels are presented, and the spots numbered according to the 
2D fluorescence difference gel electrophoresis color image. Spots were identified by MS analysis, and were named according.to the SwissProt database. 
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AFB : amniotic fluid before plug 
AFA: amniotic fluid after plug 
TFB : tracheal fluid before plug 
TFA: tracheal fluid after plug 
Fig. 2. Comparison of the 20 patterns of AF proteins before and after plug, from patients with congenital diaphragmatic hernia (COH). Samples were either analyzed 
using 20-DIGE and "stained with Cy5 (false color red) or Cy3 (false color green) or with 2-0E and silver staining (labeled AgN03). The regions that showing the 
most evident acidic shifts are highlighted by frames, tabeled A for the album in area, and B for that of apolipoprtein-A 1. Zooms of these regions are presented in the 
tower panel. No specific AF or TF protein spot was detected by these 20 technologies. Accumulation of acidic from of most proteins was observed in TF before 
plug. 
sampi es (N = 3 at 28 weeks of gestation and N = 3 at 34 weeks 
of gestation), but was not related to the disease. When the three 
groups (AF at term, AF at 17 weeks and AF with CDH) were 
compared, AF with CDH did not segregate as a single group, 
indicating the absence of protein spots specific of the diseases 
on the 2D gels of AF. As shown by Fig. 2A-C, differences were 
observed between AFB and AFA. When the merged image was 
evaluated, the left side of many spots stained in green, indicating 
an acidic shift of the proteins before plug (AFB was stained with 
the green Cy3). This phenomenon was even more marked when 
TFB (in this case stained with the red Cy5) was compared with 
TFA (Fig. 2D-F). Standard MS/MS analyses did not allow to 
identify particular biochemical modifications that can explain 
this acidic shift. When silver stained gels were analyzed, no 
specific spot of CDH were observed either in AF or in TF, before 
or after plug. 
3.3. AF proteins in plasma 
As a mode! of PROM, plasma and AF at term were mixed at 
different ratio to dete1mine the minimal amount of AF protein 
detectable in plasma. AF (Fig. 3A, stained with Cy5 in red) and 
plasma (Fig. 3B, stained with Cy3 in green) have many common 
proteins which stained in yellow in the merged image (Fig. 3C), 
with an acidic shift for AF proteins. Many spots were stained in 
red, representing the AF proteins being largely more abundant 
compared to plasma, whereas spots in green were spots more 
abundant in plasma. The two fragments of agrin and perlecan 
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Amniotic fluid 50~19 
Plasma 50~19 
Cy3 : plasma 50~19 
Cy5 : amniotic fluid 50µ9 
000468 
A9rin 
Q9H3V5 
Perlecan 
Cy3 : plasma 50µ9 
Cy5 : plasma 40µ9 + amniotic fluid 10~19 
Fig. 3. Comparative analysis of plasma and amniotic ftuid proteins. Color images show comparison of the 20 patterns of AF at term, 50 µ,g of proteins "stained" 
using 400 pmol of CyS (false col or in red, inset A) and of the 50 µ,g of proteins of the corresponding maternai plasma, "stained" using 400 pmol of Cy3 (false col or in 
green, inset B). Both sample were mixed and loaded on immobilized four to seven non linear pH gradient followed by second dimension (9 to 16% polyacrylamide 
gel electrophoresis). The composite image (inset C) reveals proteins spots that are more abundant in AF in red, whereas those being more abundant in plasma are 
in green. Common proteins stain in yellow. Note, that for most AF protein present in plasma, an acidic shift is observed. When AF proteins were added to plasma 
(inset D), they were only detected when at least 10% of the total amount loaded were from AF (inset E). 
(Fig. 3D), previously identified as AF "specific" proteins [9] 
were unambiguously observed when AF proteins represented at 
least 10% of the total amount of proteins loaded (Fig. 3E). 
4. Discussion 
Our results confirm that the protein profile of AF is dynamic 
and that changes occur during development. Sorne proteins are 
more abundant early in pregnancy, other being more expressed 
at term. These observations are particularly important when 
biomarkers of a specific condition are identified, because ade-
quate age-matched contrais must be used. The normal protein 
profile of AF cannot be established without having normal sam-
ples from different fetuses at different stages of gestation. This 
critical point was confirmed when AF at 17 weeks of gestation 
was compared with AF of fetuses presenting with CDH. The 
342 P-A. Queloz et al./ J. Chromatog1: B 850 (2007) 336-342 
group of control was inadequate, and the spots discriminating the 
two groups by heuristic classification were those discriminating 
the "age" of AF. 
The 2-DE analyses of AF and TF of patients with CDH did 
not reveal specific protein spots of the disease. However, impor-
tant changes of the protein patterns were clearly evidenced by 
2D-DIGE, and an acidic shift was detected according to the par-
ticular differences highlighted. The etiology of CDH remains 
largely unknown, but various genetic abnormalities have been 
recently identified [15, 16]. It affects 1 out of 2000 to 5000 live 
births. CDH can now be accurately diagnosed by mid-gestation, 
and the outcome in individual cases can be predicted on the basis 
of sonographic measurements of the lung-to-head ratio and the 
presence or absence of liver herniation in the thorax [17,18] . 
The aim of the proteomic studies was to determine if specific 
pulmonary proteins, secreted by respiratory epithelium, could 
be isolated and later used as a tool to evaluate the pulmonary 
response to the tracheal occlusion. The samples were collected 
during fetoscopic tracheal occlusion, which is nowadays consid-
ered as a minimally invasive fetal therapy, improving outcome 
in highly selected cases [19,20]. No specific protein spot was 
identified in AF or TF before or after the plug. However, an 
important acidic shift of man y pro teins was observed in AF, and 
was particularly marked in TF samples before plug. The ori-
gin of the acidic shift is presently not known, but most likely 
reflects the presence of "aged" oxidized proteins, which accu-
mulate in TF, because of the absence of respiratory movements 
due to the hernia in the thorax. Most likely, the acidic shift of 
the TF proteins is a consequence rather as being the cause of 
CDH. However, using our MS technologies, we were unable to 
characte1ize the biochemical origin of the acidic shits observed. 
The characterization of the AF proteome is in progress 
[3,9,21]. However, when 2-DE based technologies are used for 
comparative studies, an important limitation is the am~u~t of 
proteins which are present in both plasma and AF. Here, in 
order to imitate the mixed AF and blood leakage occurring 
in PROM, AF proteins were added to plasma. When AF pro-
teins represented less than 10% of the total amount of proteins 
loaded, it was not more possible to identify AF specific proteins 
using 2D-based technologies. These results indicate that 2-DE 
is ail but optimal for proteomic studies of cervical fluid, at least 
for PROM biomarker identification. Other approaches, such 
as surface-enhanced laser desorption ionization time-of-flight 
mass spectrometry, appear to be more suitable for identifying 
markers of intra-amniotic inflammation in cervical fluid [22] . 
These methods could be a potential approach to diagnosis arnni-
otic fluid embolism. This pathology is a catastrophic syndrome 
occurring during pregnancy or in the immediate post-partum, 
linked with an abnorrnal presence of AF in blood [23]. Up to 
date, the diagnosis of the amniotic fluid embolism is difficult, 
our results clearly show that two-dimensional el~ctrophoresis 
technologies still have place for analyzing biological fluids such 
as AF. 
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